MedTrace Logo

Magnetic Nanoparticle Sperm Separation for Teratozoospermia Male and Women Older Than 35 Years

NCT03666364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2019-11-18

No results posted yet for this study

Summary

Women over 35 years old are likely to suffer from impaired oocyte repair capacity. Teratozoospermia is a condition reflects morphological affection of sperm. These spermatozoa would add an extra burden on the oocyte after ICSI. Whether selecting mature sperm by magnetic nanoparticle protocol would provide a more competent sperm to a likely affected oocyte would improve ICSI outcomes is the question of this research.

Conditions

Interventions

OTHER

Sperm preparation for ICSI

A new protocol for sperm preparation for ICSI cycles with teratozoospermia in over 35 years old women

Sponsors & Collaborators

  • Banon IVF Center Assiut, Egypt

    collaborator OTHER

  • Ibn Sina Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2019-09-20
Completion
2019-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03666364 on ClinicalTrials.gov